Karyopharm Therapeutics competitorsClear all
Karyopharm Therapeutics's top competitors include Mirati Therapeutics, Northwest Biotherapeutics, Calithera Biosciences and AVEO Pharmaceuticals.
| Save Comparison |  Karyopharm Therapeutics Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases. |  Mirati Therapeutics Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of oncology products including candidates intended to treat specific genetic and epigenetic drivers of cancer in selected subsets of cancer patients with unmet needs. |  Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. |  Calithera Biosciences Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. |  AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |
Founding Date | Founding Date 2008 | Founding Date 2013 | Founding Date 1998 | Founding Date 2010 | Founding Date 2001 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Newton, US HQ München, DE Tel Aviv Yafo, IL | Locations San Diego, US HQ | Locations Bethesda, US HQ | Locations South San Francisco, US HQ | Locations Cambridge, US HQ Boston, US |
Employees | Employees 4372% increase | Employees 11176% increase | Employees 1721% increase | Employees 798% increase | Employees 1912% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 9.8 b | Valuation ($) 1.3 b | Valuation ($) 209.6 m | Valuation ($) 224.4 m |
Twitter followers | Twitter followers N/A | Twitter followers 328 | Twitter followers 2.3 k | Twitter followers N/A | Twitter followers 907 |
Alexa Website Rank | Alexa Website Rank 169517 | Alexa Website Rank 268626 | Alexa Website Rank 616184 | Alexa Website Rank 375410 | Alexa Website Rank 419832 |
Employee Rating | Employee Rating 4 | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.7 |
Financial | |||||
Revenue (est.) | Revenue (est.) $40.9m (FY, 2019) | Revenue (est.) $3.3m (FY, 2019) | Revenue (est.) $2.4m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $28.8m (FY, 2019) |
Net income | Net income ($199.6m) (FY, 2019) | Net income ($213.3m) (FY, 2019) | Net income ($20.3m) (FY, 2019) | Net income ($89.9m) (FY, 2019) | Net income $9.4m (FY, 2019) |
Operating ⚠ | |||||
Patents Issued | Patents Issued 10 (FY, 2015) | Patents Issued 32 (FY, 2016) | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A |
Funding | |||||
Total funding raised | Total funding raised $ 248.7m | Total funding raised N/A | Total funding raised $ 135.9m | Total funding raised $ 105m | Total funding raised $ 224m |
For sources of this data, please see the company profile
View company profiles
Mirati Therapeutics
HQ
San Diego, US
Employees
111
Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of oncology products including candidates intended to treat specific genetic and epigenetic drivers of cancer in selected subsets of cancer patients with unmet needs.
View companyNorthwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View companyCalithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
View companyAVEO Pharmaceuticals
HQ
Cambridge, US
Employees
19↑ 12% increase
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
View company